Galapagos

(NASDAQ) LKFT

Current PriceN/A

Market CapN/A

Since IPO (2008)+269%

5 Year-58%

1 Year+7%

1 Month+6%

Galapagos Financials at a Glance

Market Cap

N/A

Revenue (TTM)

€1.04B

Net Income (TTM)

€488.78M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 10, 2026

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 10, 2026

LKFT News

Galapagos and Gilead Sciences Post Successful Yet Disappointing Filgotinib Results

Cory RenauerMay 21, 2020

Is Galapagos Stock a Buy?

David HaenApr 12, 2020

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Galapagos

Industry

Biotechnology

Sector

Health Care

Employees

452

CEO

Henry O. Gosebruch, CPA

Website

www.galapagos.com

Headquarters

Mechelen, 2800, BE

LKFT Financials

Key Financial Metrics (TTM)

Gross Margin

98.01%

Operating Margin

57.14%

Net Income Margin

46.83%

Return on Equity

16.88%

Return on Capital

15.46%

Return on Assets

14.49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

€1.02B

Operating Income

€596.40M

EBITDA

€475.75M

Operating Cash Flow

-€301.60M

Capital Expenditure

-€8.73M

Free Cash Flow

-€310.33M

Cash & ST Invst.

€2.98B

Total Debt

€6.44M

Galapagos Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

€6.48M

N/A

Gross Profit

€1.68M

N/A

Gross Margin

25.95%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

452

N/A

Net Income

€14.49M

N/A

EBITDA

€13.96M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

€2.98B

N/A

Total Debt

€6.44M

N/A

Accounts Receivable

€54.03M

N/A

Inventory

€17.69M

N/A

Long Term Debt

€4.85M

N/A

Short Term Debt

€1.58M

N/A

Return on Assets

14.49%

N/A

Return on Invested Capital

18.23%

N/A

Free Cash Flow

-€82.87M

N/A

Operating Cash Flow

-€82.75M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,383.58-0.01%

^DJIDJI

^DJIDJI$51,733.23+0.00%

^IXICNASDAQ

^IXICNASDAQ$25,693.02-0.02%

BTCBitcoin

BTCBitcoin$62,297.00-0.04%

SPCXSPCX

SPCXSPCX$160.35+0.04%

AAPLAAPL

AAPLAAPL$298.59+0.01%

AMZNAMZN

AMZNAMZN$234.85+0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$132.39-0.06%

NVDANvidia

NVDANvidia$200.32-0.04%

AAPLApple

AAPLApple$294.83-0.01%

QBTSD-Wave Quantum

QBTSD-Wave Quantum$25.10+0.03%

TSLATesla

TSLATesla$382.02-0.06%

AMZNAmazon

AMZNAmazon$234.39+0.01%

RGTIRigetti Computing

RGTIRigetti Computing$21.29-0.00%

Questions About LKFT

What is the current price of Galapagos?

Galapagos is trading at N/A per share.

What is the 52-week range for Galapagos?

Over the past 52 weeks, Galapagos has traded between N/A and N/A.

How much debt does Galapagos have?

As of the most recent reporting period, Galapagos reported total debt of €7.41M.

How much cash does Galapagos have on hand?

Galapagos reported €76.97M in cash and cash equivalents in its most recent financial results.

What is Galapagos’s dividend yield?

Galapagos does not currently have a dividend yield.

Galapagos

Galapagos Financials at a Glance

LKFT News

Why Galapagos Trounced the Market Today

Here's Why Galapagos Stock Is Falling Today

Is Galapagos Stock a Bad-News Buy Right Now?

Why Galapagos Stock Is Crashing Today

3 Biotech Stocks With Big Incoming Catalysts

Better Buy: Vertex Pharmaceuticals vs. Galapagos

Galapagos and Gilead Sciences Post Successful Yet Disappointing Filgotinib Results

Is Galapagos Stock a Buy?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Galapagos

LKFT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Galapagos Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LKFT

What is the current price of Galapagos?

What is the 52-week range for Galapagos?

How much debt does Galapagos have?

How much cash does Galapagos have on hand?

What is Galapagos’s dividend yield?

Premium Investing Services